Jacie Bryant
Special Projects @Association for Corporate Growth (ACG)
Signup · Get unlimited contacts
WORK HISTORY
Special Projects @Association for Corporate Growth (ACG)
Los Angeles, CA, US
Support the development of ACG Los Angeles’ PODs (Professionals Opening Doors) program, an initiative designed to facilitate relationship-building and business referrals among middle-market professionalsCoordinate cross-functional efforts with attorneys, investment bankers, and investors to structure and scale small-group networking cohortsContribute to weekly and bi-weekly strategy meetings with the POD leadership team to refine program structure, define member expectations, and support ongoing rollout initiativesDesign and manage member intake and placement processes through survey development and data trackingBuild and maintain master membership and POD assignment databases in Excel and Rhythm to track engagement, participation, and program growthDraft program materials, event agendas, and member communications, including launch outreach and post-event follow-upsSupport execution of POD launch events by organizing logistics, facilitating attendee flow, and helping drive meaningful connections between membersContribute to ongoing program strategy, including quarterly review processes, membership guidelines, and scalability initiatives
EDUCATION
Northeastern University
Bachelor of Science - BS, Neuroscience
ABOUT JACIE BRYANT
I am a graduate of Behavioral Neuroscience with a strong passion for translating groundbreaking biotech innovations into market-ready therapies and, ultimately, investment opportunities. With hands-on experience in biotech business development, I’ve supported strategic partnerships, licensing discussions, investor presentations, and competitive market analyses across emerging platforms, including RNA and cell therapies. Working at the intersection of science and strategy has provided me with direct exposure to the complexities of commercialization, from early-stage scientific due diligence to identifying partners and mapping out go-to-market plans. This experience has deepened my interest in the financial mechanisms driving biotech innovation, particularly the role of investment banking in capital formation, M&A, and pipeline expansion. Now focused on healthcare and biotech investment banking, I aim to leverage my scientific background and strategic biotech experience to help innovative companies scale and succeed. I am particularly excited about opportunities to work on transformative transactions that accelerate patient access to next-generation therapies. If you are involved in the intersection of science, strategy, and finance, I would love to connect.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.